L-dopachrome tautomerase
L-dopachrome tautomerase (60-74) is a synthetic peptide fragment derived from the active region of the L-dopachrome tautomerase enzyme, also known as tyrosinase-related protein 2 (TRP-2). As a peptide compound, it represents a specific sequence within the larger protein that plays a crucial role in melanin biosynthesis and pigment cell biology. The 60-74 region of L-dopachrome tautomerase is of particular interest due to its involvement in enzymatic activity, substrate recognition, and potential regulatory functions within melanogenic pathways. Researchers utilize such defined peptide segments to dissect structure-function relationships, investigate post-translational modifications, and probe the molecular mechanisms underlying pigment production and related cellular processes.
Enzyme mechanism studies: The 60-74 peptide fragment is frequently employed in mechanistic investigations of L-dopachrome tautomerase activity. By isolating this specific region, researchers can analyze its contribution to substrate binding and catalysis, helping to elucidate how the full-length enzyme converts L-dopachrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA). Such studies are essential for understanding the fundamental biochemistry of melanogenesis and for mapping key residues involved in enzymatic function.
Epitope mapping and antibody production: The defined sequence of L-dopachrome tautomerase (60-74) serves as a valuable epitope for generating and characterizing antibodies specific to TRP-2. Synthetic peptides corresponding to this region are used to immunize host animals or as antigens in assays, enabling the production of high-affinity polyclonal or monoclonal antibodies. These antibodies are instrumental in immunodetection protocols, such as Western blotting or immunohistochemistry, facilitating the study of TRP-2 expression and localization in pigment cells and related tissues.
Peptide-protein interaction assays: Researchers utilize the 60-74 peptide to investigate protein-protein interactions relevant to melanin synthesis and pigment cell biology. By incorporating this fragment into binding assays, pull-down experiments, or surface plasmon resonance studies, it becomes possible to identify and characterize interacting partners of TRP-2. These analyses provide insights into the regulatory networks and signaling pathways that modulate melanogenic enzyme complexes.
Post-translational modification analysis: The synthetic peptide corresponding to residues 60-74 of L-dopachrome tautomerase can be used as a substrate or standard for studying post-translational modifications, such as phosphorylation or glycosylation, that may occur within this region. Analytical techniques, including mass spectrometry or HPLC, allow researchers to assess modification patterns, aiding in the understanding of how these chemical changes influence enzyme activity, stability, or subcellular localization.
Peptide-based inhibitor screening: The 60-74 fragment offers a platform for the development and screening of small molecules or peptides that modulate TRP-2 function. By utilizing this segment in competitive binding or enzymatic inhibition assays, scientists can evaluate candidate compounds for their ability to interfere with substrate recognition or catalytic activity. Such studies are vital for advancing the discovery of biochemical tools and for probing the regulatory mechanisms governing melanogenic enzymes in vitro.
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.